Senior Vice President.

Alnylam Pharmaceuticals presents data on multiple therapeutic applications at RNAi Symposium Alnylam Pharmaceuticals, Inc.D., Ph.D., D.Sc., Senior Vice President, Senior Alnylam Fellow. We are also […]

Maarten Naesens.

Maarten Naesens, M.D ., Ph.D., Line Heylen, M.D., Evelyne Lerut, M.D., Ph.D., Kathleen Claes, M.D., Ph.D., Liesbeth De Wever, M.D., Filip Claus, M.D., Ph.D., […]

The Department of Homeland Security.

Advertising campaign launched to motivate Americans practice healthy habits to avoid the spread of H1N1 flu The Department of Individual and Health Services, the Department […]

Frances Balkwill farmacia francia.

Rebecca L. Stone, M farmacia francia .D., Alpa M. Nick, M.D., Iain A. McNeish, Ph.D., Frances Balkwill, Ph.D., Hee Dong Han, Ph.D., Justin Bottsford-Miller, M.D., […]

Afif Ben Salah.

Afif Ben Salah, M.D., Nathalie Ben Messaoud, M .D., Evelyn Guedri, M.D., Amor Zaatour, Nissaf Ben Alaya, M.D., Jihene Bettaieb, M.D., Adel Gharbi, Nabil […]

A leading RNAi therapeutics company.

Alnylam commences dosing in ALN-TTR02 Phase We clinical trial for TTR-mediated amyloidosis Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, announced today that it […]

1 2